{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:00:57Z","timestamp":1783760457838,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.tiv.2009.09.018","type":"journal-article","created":{"date-parts":[[2009,9,27]],"date-time":"2009-09-27T04:21:00Z","timestamp":1254025260000},"page":"661-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis"],"prefix":"10.1016","volume":"24","author":[{"given":"Yukihiro","family":"Kuroda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2009.09.018_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2006.10.015","article-title":"Biomarkers to monitor drug-induced phospholipidosis","volume":"218","author":"Baronas","year":"2007","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1024778329320","article-title":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","volume":"19","author":"Casartelli","year":"2003","journal-title":"Cell Biology and Toxicology"},{"key":"10.1016\/j.tiv.2009.09.018_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jcp.1041370330","article-title":"Properties of binding sites for chloroquine in liver lysosomal membranes","volume":"137","author":"Colombo","year":"1988","journal-title":"Journal of Cellular. Physiology"},{"key":"10.1016\/j.tiv.2009.09.018_bib4","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib5","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","article-title":"Diversity of group types regulation, and function of phospholipase A2","volume":"269","author":"Dennis","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.tiv.2009.09.018_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF02534827","article-title":"Effect of chlorphentermine on incorporation of 14C choline in the rat lung phospholipids","volume":"21","author":"Gonmori","year":"1986","journal-title":"Lipids"},{"key":"10.1016\/j.tiv.2009.09.018_bib7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0006-2952(87)90415-1","article-title":"Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2","volume":"36","author":"Gr\u00e4bner","year":"1987","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.etp.2007.04.001","article-title":"Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS","volume":"59","author":"Hasegawa","year":"2007","journal-title":"Experimental and Toxicologic Pathology"},{"key":"10.1016\/j.tiv.2009.09.018_bib9","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/MCB.00627-06","article-title":"Lysosomal phospholipase A2 and phospholipidosis","volume":"26","author":"Hiraoka","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.tiv.2009.09.018_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2008.01.036","article-title":"Gene expression profiling in rat liver treated with compounds inducing phospholipidosis","volume":"229","author":"Hirode","year":"2008","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0006-2952(81)90451-2","article-title":"Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C","volume":"30","author":"Hostetler","year":"1981","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.tiv.2008.03.016","article-title":"Proteomic analysis of phospholipidosis in citalopram treated U937 cells \u2013 support for the cholesterol biosynthesis hypothesis","volume":"22","author":"Hutchinson","year":"2008","journal-title":"Toxicology in Vitro"},{"key":"10.1016\/j.tiv.2009.09.018_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0022-3565(25)20995-8","article-title":"Types of interaction of amphiphilic drugs with phospholipid vesicles","volume":"246","author":"Joshi","year":"1988","journal-title":"Journal of Pharmacological and Experimental Therapeutics"},{"key":"10.1016\/j.tiv.2009.09.018_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0005-2760(89)90078-7","article-title":"Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis","volume":"1004","author":"Joshi","year":"1989","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.tiv.2009.09.018_bib15","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1021\/bi980064a","article-title":"Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth","volume":"37","author":"Kaiser","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.tiv.2009.09.018_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfj067","article-title":"Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential","volume":"90","author":"Kasahara","year":"2006","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.tiv.2009.09.018_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.tiv.2009.09.018_bib18","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1021\/bi00344a031","article-title":"Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1","volume":"24","author":"Kubo","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.tiv.2009.09.018_bib19","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/0006-2952(79)90080-7","article-title":"The binding of drugs to different polar lipids in vitro","volume":"28","author":"Lullumann","year":"1979","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib20","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"Lullumann","year":"1978","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-2275(20)34331-5","article-title":"Fluorescence studies of the binding of amphiphilic amines with phospholipids","volume":"26","author":"Ma","year":"1985","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.tiv.2009.09.018_bib22","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/S0021-9258(19)70769-8","article-title":"Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4\u2032-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane","volume":"255","author":"Matsuzawa","year":"1980","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.tiv.2009.09.018_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0005-2760(80)90151-4","article-title":"Effects of chloroquine and 4,4\u2019-bis(diethylaminoethoxy)alpha, beta-diethyldiphenylethane on the incorporation of3 H glycerol into the phospholipids of rat liver lysosomes and other subcellular fractions, in vivo","volume":"620","author":"Matsuzawa","year":"1980","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.tiv.2009.09.018_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0005-2760(86)90132-3","article-title":"Alterations in rat alveolar surfactant phospholipids and proteins induced by administration of chlorphentermine","volume":"877","author":"Miles","year":"1986","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.tiv.2009.09.018_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0176-z","article-title":"Validation of an in vitro screen for phospholipidosis using a high-content biology platform","volume":"22","author":"Morelli","year":"2006","journal-title":"Cell Biology and Toxicology"},{"key":"10.1016\/j.tiv.2009.09.018_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1388-1981(02)00361-X","article-title":"Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats","volume":"1631","author":"Mortuza","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.tiv.2009.09.018_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000137487","article-title":"Pulmonary metabolism of imipramine in the rat and rabbit. Comparison with hepatic metabolism","volume":"22","author":"Ohmiya","year":"1981","journal-title":"Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-2952(82)90205-2","article-title":"Metabolism of chlorpromazine by pulmonary microsomal enzymes in the rat and rabbit","volume":"31","author":"Ohmiya","year":"1982","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000137976","article-title":"Species differences in pulmonary N-oxidation of chlorpromazine and imipramine","volume":"28","author":"Ohmiya","year":"1984","journal-title":"Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib30","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Experimental and Toxicologic Pathology"},{"key":"10.1016\/j.tiv.2009.09.018_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0300-483X(95)03175-F","article-title":"Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats","volume":"106","author":"Reasor","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2009.09.018_bib32","doi-asserted-by":"crossref","first-page":"13438","DOI":"10.1021\/jp048381g","article-title":"Distribution, orientation, and dynamics of DPH probes in DPPC bilayer","volume":"108","author":"Rep\u00e1kov\u00e1","year":"2004","journal-title":"The Journal of Physical Chemistry B"},{"key":"10.1016\/j.tiv.2009.09.018_bib33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0006-2952(85)90762-2","article-title":"Auramine O as a fluorescent probe for the binding of basic drugs to human \u03b11-acid glycoprotein (\u03b11-AG): the development of a simple fluorometric method for the determination of \u03b11-AG in human serum","volume":"34","author":"Sugiyama","year":"1985","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.tiv.2009.09.018_bib34","first-page":"347","article-title":"Molecular factors influencing retention on immobilized artificial membranes (IAM) compared to partitioning in liposomes and n-octanol","volume":"55","author":"Taillardat-Bertschinger","year":"2004","journal-title":"Pharmaceutical. Research"},{"key":"10.1016\/j.tiv.2009.09.018_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drudis.2008.11.002","article-title":"Liquid chromatography\u2013mass spectrometry in in vitro drug metabolite screening","volume":"14","author":"Tolonen","year":"2008","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.tiv.2009.09.018_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"The Journal of Toxicological Sciences"},{"key":"10.1016\/j.tiv.2009.09.018_bib37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1520-6017(200008)89:8<1085::AID-JPS13>3.0.CO;2-N","article-title":"Rapid-gradient HPLC method for measuring drug interactions with immobilized artificial membrane: comparison with other lipophilicity measures","volume":"89","author":"Valco","year":"2000","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tiv.2009.09.018_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1590\/S0100-879X2008000700001","article-title":"Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis","volume":"41","author":"Vejux","year":"2008","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.tiv.2009.09.018_bib39","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/jm7013953","article-title":"Assessment of drug-lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis","volume":"51","author":"Vitoci\u010d","year":"2008","journal-title":"Journal of Medicinal Chemistry"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233309002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233309002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:31:12Z","timestamp":1760135472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233309002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0887233309002859"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2009.09.018","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2009.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}